Nucleic acids encoding mutated human immunodeficiency virus matrix proteins
AssigneePresident and Fellows of Harvard College
InventorsMyron E. Essex, Xiaofang Yu, Tun-Hou Lee
Life of this patent
Estimating the term…
Abstract
Nucleic acid constructs encoding mutated human immunodeficiency virus matrix proteins are described. The mutated proteins lower the incorporation of envelope polypeptides in viral particles, disrupt viral assembly or disrupt viral entry into uninfected cells.
Claims24
A DNA construct comprising nucleic acid encoding a mutated human immunodeficiency virus (HIV) matrix (MA) polypeptide capable of undergoing wild-type gag proteolytic processing, said polypeptide being effective in lowering the incorporation of env polypeptides in the viral particle;
- disrupting viral assembly;
- or disrupting viral entry into uninfected cells.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of a region comprising at least one or more of amino acids 11 to 20 and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of amino acids 21 to 31 of wild-type MA polypeptide, and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of a region comprising at least one or more of amino acids 32 to 49, and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of a region comprising at least one or more of amino acids 79 to 90, and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of a region comprising at least one or more of amino acids 91 to 103, and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of a region comprising at least one or more of amino acids 105 to 114, and said mutated MA polypeptide being effective to disrupt entry of viral particles into uninfected cells.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a deletion of a region comprising at least one or more of amino acids 116 to 128, and said mutated MA polypeptide being effective to disrupt entry of viral particles into uninfected cells.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a change of amino acids trp36 and ala37 to arg and pro, respectively, and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a change of amino acid ala37 to pro, and said mutated MA polypeptide being effective to lower the incorporation of env polypeptides in the viral particle.
Nucleic acid encoding a mutated MA polypeptide, said mutated MA polypeptide containing a substitution of thr20 for arg20, and substitution of asn18, 26, 27, 28, 30 and 32 for lys18, 26, 27, 28, 30 and 32, and said mutated MA polypeptide being effective to disrupt viral assembly.
A nucleic acid construct encoding a mutated HIV matrix (MA) polypeptide, wherein said mutated MA polypeptide contains a deletion of at least one of the following regions of a wild type MA polypeptide:
- a) amino acids 5-16 of said wild-type;
- b) amino acids 11-20 of said wild-type;
- c) amino acids 21-31 of said wild-type;
- d) amino acids 32-49 of said wild-type;
- e) amino acids 79-90 of said wild-type;
- f) amino acids 91-103 of said wild-type;
- g) amino acids 105-114 of said wild-type;
- h) amino acids 116-128 of said wild-type.
A nucleic acid construct encoding a mutated HIV matrix (MA) polypeptide, wherein said mutated MA polypeptide contains at least one of the following substitutions of a wild type MA polypeptide:
- a) substitution of arg for trp36;
- b) substitution of pro for ala37;
- c) substitution of thr for arg20;
- d) substitution of glu for one or more of lys26, 27, 28, and 32;
- e) substitution of asn for one or more of lys18, 26, 27, 28, 30 and 32.
A composition comprising cells containing nucleic acid encoding a mutated MA polypeptide, said nucleic acid being in an expressible genetic construction, wherein said mutated MA polypeptide is effective in lowering the incorporation of env polypeptides in the viral particle, disrupting viral assembly, or disrupting viral entry into uninfected cells.
Dependencies are inferred from the claim text.